PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced positive interim 24-week liver biopsy results in four subjects from AROAAT2002, an open-label Phase 2 ...
American Assets Trust offers a compelling 7.1% dividend yield with a conservative 69% payout ratio, making it attractive for income investors. AAT's diversified portfolio in high-demand coastal ...
AAT is deeply undervalued, trading at a forward P/FFO of 9.6 and offering a well-covered 7.3% dividend yield near historic highs. Its high-quality coastal portfolio, strategic asset recycling, and ...
It's not always easy to get a diagnosis of alpha-1 antitrypsin (AAT) deficiency, a rare condition that sometimes leads to serious lung and liver damage. In fact, most people who have this disorder are ...
Alpha-1 antitrypsin (AAT) deficiency is a genetic disease where your body doesn’t make enough normal functioning AAT. AAT is a protein your liver makes. AAT has many important roles in your body, ...
Strategies for reducing the cellular immune response and eliminating need for receptors may improve utility of adenoviral vectors Adeno-associated viral vectors have low toxicity and effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results